Literature DB >> 24838473

Genetic and epigenetic characteristics of FSHD-associated 4q and 10q D4Z4 that are distinct from non-4q/10q D4Z4 homologs.

Weihua Zeng1, Yen-Yun Chen, Daniel A Newkirk, Beibei Wu, Judit Balog, Xiangduo Kong, Alexander R Ball, Simona Zanotti, Rabi Tawil, Naohiro Hashimoto, Ali Mortazavi, Silvère M van der Maarel, Kyoko Yokomori.   

Abstract

Facioscapulohumeral dystrophy (FSHD) is one of the most prevalent muscular dystrophies. The majority of FSHD cases are linked to a decreased copy number of D4Z4 macrosatellite repeats on chromosome 4q (FSHD1). Less than 5% of FSHD cases have no repeat contraction (FSHD2), most of which are associated with mutations of SMCHD1. FSHD is associated with the transcriptional derepression of DUX4 encoded within the D4Z4 repeat, and SMCHD1 contributes to its regulation. We previously found that the loss of heterochromatin mark (i.e., histone H3 lysine 9 tri-methylation (H3K9me3)) at D4Z4 is a hallmark of both FSHD1 and FSHD2. However, whether this loss contributes to DUX4 expression was unknown. Furthermore, additional D4Z4 homologs exist on multiple chromosomes, but they are largely uncharacterized and their relationship to 4q/10q D4Z4 was undetermined. We found that the suppression of H3K9me3 results in displacement of SMCHD1 at D4Z4 and increases DUX4 expression in myoblasts. The DUX4 open reading frame (ORF) is disrupted in D4Z4 homologs and their heterochromatin is unchanged in FSHD. The results indicate the significance of D4Z4 heterochromatin in DUX4 gene regulation and reveal the genetic and epigenetic distinction between 4q/10q D4Z4 and the non-4q/10q homologs, highlighting the special role of the 4q/10q D4Z4 chromatin and the DUX4 ORF in FSHD.
© 2014 WILEY PERIODICALS, INC.

Entities:  

Keywords:  D4Z4; DUX4; FSHD1; FSHD2; H3K9me3; SMCHD1; heterochromatin

Mesh:

Substances:

Year:  2014        PMID: 24838473      PMCID: PMC4489691          DOI: 10.1002/humu.22593

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  59 in total

1.  Improved characterization of FSHD mutations.

Authors:  Y Zhang; J Forner; S Fournet; M Jeanpierre
Journal:  Ann Genet       Date:  2001 Apr-Jun

2.  Complete allele information in the diagnosis of facioscapulohumeral muscular dystrophy by triple DNA analysis.

Authors:  P de Kievit; M van Geel; M J van der Wielen; E Bakker; G W Padberg; R R Frants; S M van der Maarel
Journal:  Ann Neurol       Date:  2001-12       Impact factor: 10.422

3.  Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy.

Authors:  Petra G M van Overveld; Richard J F L Lemmers; Lodewijk A Sandkuijl; Leo Enthoven; Sara T Winokur; Floor Bakels; George W Padberg; Gert-Jan B van Ommen; Rune R Frants; Silvère M van der Maarel
Journal:  Nat Genet       Date:  2003-11-23       Impact factor: 38.330

4.  Facioscapulohumeral muscular dystrophy is uniquely associated with one of the two variants of the 4q subtelomere.

Authors:  Richard J L F Lemmers; Peggy de Kievit; Lodewijk Sandkuijl; George W Padberg; Gert-Jan B van Ommen; Rune R Frants; Silvère M van der Maarel
Journal:  Nat Genet       Date:  2002-09-23       Impact factor: 38.330

5.  Contractions of D4Z4 on 4qB subtelomeres do not cause facioscapulohumeral muscular dystrophy.

Authors:  Richard J F L Lemmers; Mariëlle Wohlgemuth; Rune R Frants; George W Padberg; Eva Morava; Silvere M van der Maarel
Journal:  Am J Hum Genet       Date:  2004-10-04       Impact factor: 11.025

6.  The FSHD2 gene SMCHD1 is a modifier of disease severity in families affected by FSHD1.

Authors:  Sabrina Sacconi; Richard J L F Lemmers; Judit Balog; Patrick J van der Vliet; Pauline Lahaut; Merlijn P van Nieuwenhuizen; Kirsten R Straasheijm; Rashmie D Debipersad; Marianne Vos-Versteeg; Leonardo Salviati; Alberto Casarin; Elena Pegoraro; Rabi Tawil; Egbert Bakker; Stephen J Tapscott; Claude Desnuelle; Silvère M van der Maarel
Journal:  Am J Hum Genet       Date:  2013-09-26       Impact factor: 11.025

7.  The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome.

Authors:  R S Hansen; C Wijmenga; P Luo; A M Stanek; T K Canfield; C M Weemaes; S M Gartler
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

8.  A potential role for human cohesin in mitotic spindle aster assembly.

Authors:  H C Gregson; J A Schmiesing; J S Kim; T Kobayashi; S Zhou; K Yokomori
Journal:  J Biol Chem       Date:  2001-10-04       Impact factor: 5.157

9.  Loss of activity of the selenoenzyme thioredoxin reductase causes induction of hepatic heme oxygenase-1.

Authors:  Volker Mostert; Kristina E Hill; Raymond F Burk
Journal:  FEBS Lett       Date:  2003-04-24       Impact factor: 4.124

10.  The 4q subtelomere harboring the FSHD locus is specifically anchored with peripheral heterochromatin unlike most human telomeres.

Authors:  Rose Tam; Kelly P Smith; Jeanne B Lawrence
Journal:  J Cell Biol       Date:  2004-10-25       Impact factor: 10.539

View more
  22 in total

Review 1.  Facioscapulohumeral muscular dystrophy as a model for epigenetic regulation and disease.

Authors:  Charis L Himeda; Takako I Jones; Peter L Jones
Journal:  Antioxid Redox Signal       Date:  2014-12-04       Impact factor: 8.401

2.  CRISPR/dCas9-mediated Transcriptional Inhibition Ameliorates the Epigenetic Dysregulation at D4Z4 and Represses DUX4-fl in FSH Muscular Dystrophy.

Authors:  Charis L Himeda; Takako I Jones; Peter L Jones
Journal:  Mol Ther       Date:  2015-11-03       Impact factor: 11.454

3.  Individual epigenetic status of the pathogenic D4Z4 macrosatellite correlates with disease in facioscapulohumeral muscular dystrophy.

Authors:  Takako I Jones; Oliver D King; Charis L Himeda; Sachiko Homma; Jennifer C J Chen; Mary Lou Beermann; Chi Yan; Charles P Emerson; Jeffrey B Miller; Kathryn R Wagner; Peter L Jones
Journal:  Clin Epigenetics       Date:  2015-03-29       Impact factor: 6.551

4.  Identifying diagnostic DNA methylation profiles for facioscapulohumeral muscular dystrophy in blood and saliva using bisulfite sequencing.

Authors:  Takako I Jones; Chi Yan; Peter C Sapp; Diane McKenna-Yasek; Peter B Kang; Colin Quinn; Johnny S Salameh; Oliver D King; Peter L Jones
Journal:  Clin Epigenetics       Date:  2014-10-29       Impact factor: 6.551

5.  PARP1 Differentially Interacts with Promoter region of DUX4 Gene in FSHD Myoblasts.

Authors:  Vishakha Sharma; Sachchida Nand Pandey; Hunain Khawaja; Kristy J Brown; Yetrib Hathout; Yi-Wen Chen
Journal:  J Genet Syndr Gene Ther       Date:  2016-08-08

6.  Polycomb repressive complex 1 provides a molecular explanation for repeat copy number dependency in FSHD muscular dystrophy.

Authors:  Valentina Casa; Valeria Runfola; Stefano Micheloni; Arif Aziz; F Jeffrey Dilworth; Davide Gabellini
Journal:  Hum Mol Genet       Date:  2017-02-15       Impact factor: 6.150

7.  CRISPR mediated targeting of DUX4 distal regulatory element represses DUX4 target genes dysregulated in Facioscapulohumeral muscular dystrophy.

Authors:  Sunny Das; Brian P Chadwick
Journal:  Sci Rep       Date:  2021-06-15       Impact factor: 4.379

8.  Increased DUX4 expression during muscle differentiation correlates with decreased SMCHD1 protein levels at D4Z4.

Authors:  Judit Balog; Peter E Thijssen; Sean Shadle; Kirsten R Straasheijm; Patrick J van der Vliet; Yvonne D Krom; Marlinde L van den Boogaard; Annika de Jong; Richard J L F Lemmers; Rabi Tawil; Stephen J Tapscott; Silvère M van der Maarel
Journal:  Epigenetics       Date:  2015       Impact factor: 4.528

9.  Influence of Repressive Histone and DNA Methylation upon D4Z4 Transcription in Non-Myogenic Cells.

Authors:  Sunny Das; Brian P Chadwick
Journal:  PLoS One       Date:  2016-07-28       Impact factor: 3.240

10.  The effect of Nipped-B-like (Nipbl) haploinsufficiency on genome-wide cohesin binding and target gene expression: modeling Cornelia de Lange syndrome.

Authors:  Daniel A Newkirk; Yen-Yun Chen; Richard Chien; Weihua Zeng; Jacob Biesinger; Ebony Flowers; Shimako Kawauchi; Rosaysela Santos; Anne L Calof; Arthur D Lander; Xiaohui Xie; Kyoko Yokomori
Journal:  Clin Epigenetics       Date:  2017-08-25       Impact factor: 6.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.